Ryerson Hldg Corp SEC Filings

Molly D. Kannan, Chief Accounting Officer and Corporate Controller of Ryerson Holding Corp (RYI), reported acquisitions of dividend equivalent rights tied to restricted stock units (RSUs). Each RSU represents a contingent right to one share of RYI common stock. On 09/18/2025 she acquired dividend equivalent amounts of 16.613, 32.496 and 53.758 share equivalents, which increased her beneficial ownership in the underlying common stock to 2,074.819, 4,058.497 and 6,713.948 respectively. The accrued dividend equivalents relate to RSU grants from March 31, 2023, 2024 and 2025 and will vest on specified dates between March 31, 2026 and March 31, 2028 under the awards' original vesting schedules.

James J. Claussen, Executive Vice President & Chief Financial Officer of Ryerson Holding Corp (RYI), reported the grant and accrual of restricted stock units (RSUs) and related dividend equivalent rights on 09/18/2025. Each RSU represents a contingent right to one share of common stock and the reported dividend equivalents were granted at $0 price. The filing shows cumulative beneficial ownership following the transactions of 4,149.637, 8,115.974 and 13,427.895 shares tied to RSU awards granted March 31, 2023, 2024 and 2025. The awards remain unvested with scheduled vesting dates through March 31, 2028. The form was signed by attorney-in-fact on 09/22/2025.

Ryerson Holding Corp (RYI) director and President & CEO Edward J. Lehner reported acquisitions on 09/18/2025 of dividend-equivalent rights associated with three separate restricted stock unit awards. The filings show additions of 104.412, 204.232, and 295.666 restricted stock units (RSUs) at $0 price, reflecting accrued dividend equivalents; following these transactions the filings list beneficial ownership amounts of 13,040.261, 25,507.19, and 36,926.71 common shares respectively. The RSUs vest on future dates: the 2023 grant vests March 31, 2026; the 2024 grant vests March 31, 2026 and March 31, 2027; the 2025 grant vests March 31, 2026, March 31, 2027, and March 31, 2028. The Form 4 was signed by an attorney-in-fact on 09/22/2025.

Insider sale disclosed: Ryerson Holding Corporation (RYI) Form 4 shows that Sundarrajan Alagu, Chief Information Officer and reporting person, sold 15,000 shares of Ryerson common stock on 08/28/2025 at a price of $22.47 per share. After the reported sale, the filing shows the reporting person beneficially owns 17,005.4521 shares. The filing includes an explanatory note that the shares were sold in multiple transactions at $22.47 and that the reporting person will provide details of the number of shares sold upon request. The form is signed by Camilla Rykke Merrick on 09/02/2025.

Ryerson Holding Corporation (RYI) Form 144 notice: An individual proposes to sell 15,000 shares of Ryerson common stock through Fidelity Brokerage Services LLC on the NYSE, with an approximate aggregate market value of $337,008.83. The filing shows total shares outstanding of 32,198,906 and an approximate sale date of 08/28/2025. The shares were acquired in two tranches: 10,000 shares bought on 12/13/2018 in an open-market cash purchase, and 5,000 shares that vested as restricted stock on 03/31/2025 as compensation. The filer reports no securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known to the seller.

Insider sale disclosed by Ryerson Holding Corp (RYI) Molly D. Kannan, listed as CAO & Corporate Controller and an officer/director, reported a sale of 2,528 shares of Ryerson common stock on 08/20/2025. The Form 4 shows the transaction coded as a sale (S) and lists a price of $22.24 with a footnote stating the shares were sold in multiple transactions at $22.42. Following the reported disposition, the filing lists 23,516.4636 shares beneficially owned by the reporting person, held directly. The form is signed and dated 08/22/2025 by the reporting person.

Form 144 notice filed for Ryerson Holding Corporation (RYI) reporting a proposed sale of 2,528 common shares valued at $56,680.11. The shares were acquired on 03/31/2025 through restricted stock vesting as compensation and the filer indicates no sales of issuer securities in the past three months. The proposed approximate sale date is 08/20/2025 on the NYSE. The filing includes the filer’s representation that they are not aware of any undisclosed material adverse information about the issuer.